In addition, our GSEA results confirmed the relevance our ZF-TF approach, as our common fulvestrant resistance gene expression signature demonstrated highly significant overlap with multiple previously described breast cancer anti-hormonal resistance gene sets. The gene discussed is TF; the disease is breast carcinoma.